| Description |
Dear Colleague,
The 2nd Annual Rediscovering Biomarkers Conference exposes attendees to the latest advancements and developments in biomarkers and predictive medicine. Attendees gain insight into discovery and development processes, hear about new biomarkers and upcoming trends in the industry, as well as the status of those in clinical trials. Delegates will also receive highly valuable information on tools for improving reimbursement strategies and the efficacy and validation of biomarkers.
Sessions for the conference include:
Discovery and Development of Biomarkers
Biomarkers in Clinical Trials
Regulatory Perspective on Biomarkers
Reimbursement Strategies
Upcoming Trends and Technologies in Biomarkers
This event also provides a unique venue for attendees to network in the most comfortable and informal of settings.
We hope you can join your colleagues at this exciting forum.
Best regards,
2008 Rediscovering Biomarkers
Organizing Committee
Special Thanks to our Advisory Board:
Scott Patterson, Amgen
Herbert Fritsche, MD Anderson
Cancer Center
Henry Rodriguez, NCI
Lukas Amler, Genentech Michael Shi, novartis
joseph Paul Eder, AstrZeneca
Gary Palmer, Genomic Health
Thomas Li, Roche
Victor Levenson, Northwestern Univ.
What last year’s attendees said...
"The Rediscovering Biomarkers conference gave me a state-of-the-art view on the technical, regulatory, and scientific issues in biomarker development and utilization." - Willard Freeman, Penn State University
"I have seldom encountered a conference in which the seminars were both keenly relevant to biomarker discovery and uniformly well-presented for a broad audience of diagnostic, pharmaceutical, biotech, government, and academic scientists." - Marc G. Taylor, Ph.D. Director, Biomarker Discovery Siemens Medical Solutions Diagnostics
|
|
